The FFD’s Diabète LAB is investigating the interaction between artificial intelligence and continuous glucose monitors.
The results show that AI, to some extent, complements and facilitates diagnosis, glucose monitoring, and decision-making.
However, in my view, it is important not to lose sight of the influence AI exerts and the potential for errors.
AI is being touted everywhere, but we must be careful: the human element must remain at the heart of decision-making. AI should serve as a complement to diagnosis, not the sole option.
To form your own opinion, I invite you to consult the article and the LAB’s findings.